GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: levy who wrote (1302)	11/1/1999 10:06:00 AM
From: out_of_the_loop	Read Replies (1) of 5582

At the time of the shareholder meeting, the article had not been rejected. Most rejected articles are rejected right away, so I think the company knew that they had to get both studies published and must have felt that they were being given the runaround (no journal is completely above politics because many editors have done research in the field they are critiquing). I think they wanted to get both results out there ASAP to be contemporaneous with the ad campaign. A sound business decision. Anyway, this is good because if this does not move the stock so as to spike significantly, and its base continues higher - and the shorts do ot cover, the second study results (preventive effects and known viral stran exposure) will cause the spring to tighten. The bottom line is that when there is real news, it will be picked up.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next